抗结核活动的7-Methyljuglone-Loaded多- ((乳酸合糖化物) 纳米颗粒的抗结核活动
Bianca Diedericks1, Anna-Mari Kok1,2, Vusani Mandiwana3
1Department of Plant and Soil Sciences, University of Pretoria, Pretoria 0002, South Africa.
Pharmaceutics
|November 27, 2024
概括
装有7-甲基隆 (7-MJ) 的聚乳糖合糖酸 (PLGA) 纳米颗粒显示出细胞毒性降低和改善结核病 (TB) 治疗的潜力. 这些纳米粒子被细胞有效地吸收,这表明药物输送系统的前景.
科学领域:
- 自然产品药物输送天然产品药物输送
- 纳米医学用于传染病.
- 基于聚合物的药物载体.
背景情况:
- 自然产品正在探索用于治疗诸如结核病 (TB) 等疾病.
- 聚--乳酸-同-葡萄糖) 酸 (PLGA) 纳米粒子作为药物输送系统正在被研究.
- 研究了来自*Euclea natalensis*的化合物7-甲基隆 (7-MJ).
研究的目的:
- 为了研究PLGA纳米颗粒加载7-甲基隆 (7-MJ) 的使用.
- 评估7-MJ及其PLGA纳米粒子的抗菌和细胞毒性作用.
- 为了评估7-MJ PLGA纳米颗粒的细胞吸收.
主要方法:
- 对 *Mycobacterium smegmatis* 和 *Mycobacterium tuberculosis* (对药物敏感和MDR) 的抗菌活性测试.
- 使用差异化U937细胞进行细胞毒性评估.
- 吞研究以确定U937细胞的纳米粒子吸收.
主要成果:
- 7-MJ表现出抗菌菌活性,MIC值为1.6微克/毫升和0.4微克/毫升.
- 免费的7-MJ对U937细胞表现出细胞毒性 (IC50为3.25μg/mL).
- 7-MJ PLGA纳米颗粒的细胞毒性降低了80倍,并被U937细胞吸收.
结论:
- PLGA纳米颗粒提供了一个潜在的策略来降低7-MJ的细胞毒性.
- 这项研究表明,使用PLGA纳米粒子改善了结核病治疗的交付可能性.
- 纳米粒子配方增强了天然产品的治疗潜力.
相关概念视频
Drugs that Stabilize Microtubules
2.2K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
226
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
226
Site-Targeted Drug Delivery Systems: Polymeric Carriers
165
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
165


